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ABSTRACT
We report the case of a patient with cutaneous leishmaniasis who showed a rapidly 
progressing ulcerative lesion after traveling to multiple countries where different Leishmania 
species are endemic. Diagnosis of Leishmania tropica, an exotic species in Mexico was 
established by using serological and molecular tools.
KEYWORDS: Leishmania tropica. Molecular epidemiology. Local cutaneous leishmaniasis. 
Travel medicine.
INTRODUCTION
Human cutaneous leishmaniasis is a zoonotic emerging tropical disease caused 
by 20 species of flagellated protozoa of the genus Leishmania, generating 150,000 
new human cases per year, that are distributed across 98 countries throughout the Old 
World and the New World1-3. Most of the Old World cases are caused by Leishmania 
aethiopica, Leishmania infantum, Leishmania major and Leishmania tropica, 
whereas in the New World they are mostly caused by Leishmania amazonensis, 
Leishmania braziliensis, Leishmania mexicana, Leishmania naiffi and Leishmania 
panamensis3,4.
Many of the species cause ulcers with indurated borders, which are 
indistinguishable between the species, thereby making the differential diagnosis very 
complicated5-7. Yet a species-specific diagnosis is crucial since some Leishmania 
species generate visceral or mucocutaneous forms of the disease (L. infantum and 
L. braziliensis respectively)3,8. Currently, no morphological parameters exist that 
permit to distinguish between Leishmania species6,7. The increasing worldwide 
travel, ecoturism and displacement of migrants are affecting the distribution and 
incidence of patients with leishmaniasis, especially in the Middle East countries 
where L. major and L. tropica are the main pathogenic species9-11. In Mexico, most 
of the cutaneous leishmaniasis cases are caused by L. mexicana12,13. Yet, isolated 
reports of other species such as L. amazonensis, L. braziliensis and L. infantum/
chagasi have also been registered13. The surveillance of Leishmania species that 
circulate in a region is essential to alert health authorities of the introduction of exotic 
species that can affect vulnerable groups and also helps to establish the degree of 
dissemination or flow of these species within non-endemic regions2-4. 
We report the case of a patient with LCL who showed a rapidly progressing 
ulcerative lesion after travelling to multiple countries where different Leishmania 
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species are endemic. Diagnosis of leishmaniasis was 
established serologically and by smears, yet PCR enabled 
us to establish that the patient was infected by Leishmania 
tropica, an exotic species in Mexico. We highlight the 
importance of including a species-specific diagnosis by 
PCR to establish the Leishmania species and the possible 
infection site in travellers exposed to multiple species. 
CASE REPORT
A 35-years-old male patient, originally from Russia, 
attended the Dermatology Service of the General Hospital 
in Mexico due to two ulcerative skin lesions with a 
semi-dry appearance, active borders, one of which was 
in the lower left pre-atrial region and the other in the 
dorsal region of the left forearm (Figure 1A). The patient 
referred having travelled to different Middle Eastern 
countries (Israel, Turkey), and to the Balkan region 
(Armenia, Georgia) and Russia, between May and June 
2019. In August of the same year, he detected red and 
indurated papules, leading him to seek medical attention 
in San Cristobal de las Casas, located in the Mexican 
State of Chiapas, in late August. Cryotherapy with liquid 
nitrogen was applied to the lesions, leading to their 
temporary reduction in size. After a renewed flare-up of 
the lesion edges, the patient was attended at the Tropical 
Medicine Center (UNAM/Hospital General de Mexico), 
where he was clinically diagnosed as having localized 
cutaneous leishmaniasis (LCL). For the confirmation, 
Giemsa-stained smears of the lesion and ELISA tests 
for L. braziliensis, L. infantum/chagasi, L. major and 
L. mexicana were carried out14. Additionally, an aspirate 
of the lesion was performed and the recovered material 
was grown in NNN medium (Novy-MacNeal-Nicolle) and 
in 199 Hank’s culture medium (Cat. 12350039, Gibco, 
Burlington, Ontario, Canada), supplemented with 10% 
decomplemented fetal bovine serum- FBS (Cat. 16000044, 
Gibco, Burlington, Ontario, Canada). The quickly growing 
promastigotes were used for species identification. To this 
end, promastigote DNA was extracted with DNeasy Blood 
& Tissue kit (QIAGEN Inc., Hilden, Germany) following 
the manufacturer’s guidelines. For the PCR analysis, a 
589 bp segment of the alanine aminotransferase gene 
(ALAT), a 350 bp of the heat shock protein 70 (hsp70) and 
300 bp of the internal transcribed spacer 1 (ITS1)15,16 were 
amplified using 25 µL QIAGEN Master mix (QIAGEN 
Inc., Hilden, Germany), 1 µL (10 µM) of each primer 
(ALAT: Fwd 5´-GTGTGCATCAACCCMGGGAA-
3´and Rvs 5´-CGTTCAGCTCCTCGTTCCGC-3´; 
Hsp70: Fwd 5´-GGACGAGATCGAGCGCATGGT-3´ 
and Rvs 5´-TCCTCCGACGCCTCCTGGTTG-3´; 
ITS1: Fwd 5´-CTGGATCATTTTCCGATG-3´ and Rvs 
5´-TGATACCACTTATCGCAC-3´ ), 2-3 µL of extracted 
DNA and bi-distilled sterile water in a final volume of 
50 µL. Additionally, L. mexicana DNA and bi-distilled 
sterile water were used as positive and negative controls, 
respectively. We followed the amplification conditions 
previously reported15,16. The PCR products were run on 
a 1% agarose gel stained with Smartglow (Cat. E4500-
PS, Accuris Instruments, Edison, NJ, USA). The PCR 
products were purified using the Agencourt AMPure XP 
kit (Cat. A63882, Beckman Coulter, Brea, CA, USA). 
Amplicons were sequenced using the BigDye Terminator 
v3.1 Cycle Sequencing Kit (Cat. 4337455, Thermo 
Fisher, Waltham, MA, USA). The sample was purified 
by the BigDye XTerminator (Cat. 4376486, Thermo 
Fisher, Waltham, MA, USA) prior to loading on the 
ABI 3730xL DNA analyzer (Thermo Fisher, Waltham, 
MA, US). Sequencing was carried out at the Sequencing 
Unit of the National Institute of Genomic Medicine. 
Figure 1 - Photographs of the ulcer on the forearm: A) active injury; B) injury after the glucantime treatment.
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Chromatograms were visualized and a consensus sequence 
was generated using the Chromas software (version 5, 
Technelysium, South Brisbane, QLD, Australia). The 
consensus sequence was compared to reference sequences 
deposited in GenBank using the BLASTn tool (National 
Center for Biotechnology Information, Bethesda, MD, 
USA). Sequences of validated Leishmania species were 
downloaded and a global alignment was conducted 
using the Clustal W algorithm (Informer Technologies, 
Inc., Dallas, US) with the software Bioedit (Informer 
Technologies, Inc., Dallas, US). Finally, a Maximum 
Likelihood phylogenetic reconstruction was carried out 
using the Tamura-three parameters model with invariant 
sites (I) with 10,000 Bootstrap replicates in Mega 6.0. 
Gaps were excluded from the analysis. Sequences were 
deposited in GenBank under the accession numbers 
MT157311, MT157312, and MT140349.
The Giemsa-stained smears of the lesion showed 
abundant amastigotes within macrophages. The ELISA 
analyzed the patient’s serum revealing some degree of cross 
reactivity between four Leishmania species: L. braziliensis, 
L. infantum/chagasi, L. major and L. mexicana, yet higher 
antibody levels were recorded for L. major and L. mexicana 
antigens (Table 1). The isolated parasites were used for 
the PCR evaluation and a successful amplification of 
the three genes was achieved (Figures 2A, 2B and 2C). 
Using the BLAST analysis, these consensus sequences 
were 99% (538/544 bp), 100% (323/323 bp), and 100% 
(277/277 bp) identical to the corresponding sequences 
of the ALAT (MH455379), hsp70 (LN907846), and ITS1 
(FN677341), genes respectively, of L. tropica from Israel 
and Russia. For the phylogenetic analyses, we only included 
fragments of 540, and 320 bp of the ALAT, and hsp70 genes, 
respectively. The Maximum Likelihood analysis confirmed 
that the parasite recovered from the patient corresponded to 
L. tropica (Figures 2D and 2E). The patient was treated with 
intralesional applications of 1 mL of glucantime per lesion 
at 5-day intervals with outpatient monitoring for 4 weeks. 
The case resolved favorably, the lesions healed adequately 
and the patient was discharged (Figure 1B).
Table 1 - The mean optical densities (OD) recorded in ELISA test for each Leishmania species.
Species OD Cut point Result Interpretation
Leishmania braziliensis 0.501 0.249 0.252 Borderline
Leishmania infantum/chagasi 0.356 0.178 0.178 Borderline
Leishmania major 0.435 0.191 0.244 Positive
Leishmania mexicana 0.548 0.204 0.344 Positive
Figure 2 - Molecular identification of Leishmania tropica: A) ALAT. PCR products of parasites isolated from the patient in lines 1 
and 2 (3 and 2 µL, respectively), Leishmania mexicana positive control (line 3), Nuclease-free water as the negative control (line 4). 
L=Ladder 100 pb; B) hsp70-C) ITS1. PCR products of parasites isolated from the patient in lines 1 and 3 (3 and 2 µL, respectively), 
positive control (line 5), and negative control (line 4); D) Maximum Likelihood phylogenetic trees generated using the Tamura three-
parameter distance model with Invariant sites (+I) with partial sequences of the ALAT gene, and E) Hasegawa-Kishino-Yano with 
Gamma distribution (+G) of the hsp70 gene from several members of the genus Leishmania. Bootstrap values greater than 50 are 
indicated on the nodes. The sequences generated in this study are indicated with red triangles.
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DISCUSSION
The molecular epidemiology of human imported cases 
of leishmaniasis is lacking in Mexico12,13. To the best of 
our knowledge, this case represents the first record of LCL 
caused by Leishmania tropica reported in Mexico. This 
species is registered mainly in the Middle Eastand Russia, 
representing one of the most widely distributed species 
causing cutaneous leishmaniasis in the Old World5,7,17,18. 
The incidence of this pathogen has increased in the urban 
areas of Israel and also in regions with armed conflicts in 
the Middle East16. Although the patient had visited several 
areas where L. tropica is endemic, he had also visited 
various States of Mexico, endemic for L. mexicana1,13. 
Thus, a species-specific diagnosis was mandatory. This was 
achieved by using molecular tools that enabled to detect the 
presence of L. tropica, an exotic microorganism in America. 
The rapid and correct detection of an infecting Leishmania 
species is important for establishing the correct treatment 
and the clinical management of the patients5,7. Furthermore, 
the correct identification of Leishmania species in travelers 
helps alerting health authorities on the presence of a novel 
species within the country and enable sanitary measures 
to avoid the establishment and distribution of new sources 
of Leishmania transmission in non-endemic regions, 
where sand flies are able to transmit the parasite8,9. In 
Middle East countries, Phlebotomus sergenti, is the main 
vector of L. tropica19. Although in America there are no 
representatives of the genus Phlebotomus, in Mexico 52 
sand fly species have been recorded, four of them are 
confirmed vectors of other Leishmania species and whose 
transmission capacity of L. tropica is unknown12.
Furthermore, environmental aspects such as climate 
change, growing urbanization, socio-economic development, 
tourism and migrations are changing the epidemiology of 
leishmaniasis9-11. This highlights the need of establishing 
the molecular diagnostic as an essential tool for the active 
surveillance to avoid the emergence of outbreaks of exotic 
parasites. 
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